Molecular profiling of biliary cancers reveals distinct molecular alterations and potential therapeutic targets

Abstract

These findings support clinical molecular profiling of BTCs to inform potential therapeutic selection and clinical trial design based on the primary tumor's site of origin within the biliary tree.